| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.8 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.8 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.9 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |